Nitrate, pooled across 20 meta-analyses: it moves time to exhaustion, muscular endurance, distance covered and peak power
And no other performance outcome, time trial and VO2max included
Key Findings
Scope: 20 placebo-controlled systematic reviews with meta-analyses, 180 primary studies, n=2672 unique participants, 11 performance domains; PROSPERO-registered.
What nitrate moves (SMD [95% CI]):
Time to exhaustion: 0.33 [0.19, 0.47]
Muscular endurance: 0.48 [0.23, 0.74]
Total distance covered: 0.42 [0.09, 0.76]
Peak power output: 0.25 [0.10, 0.39]
Time to peak power output: −0.76 [−1.18, −0.33] — reaches peak power sooner
What nitrate does not move: no significant improvement in any other performance outcome (all p > 0.05).
full text, checked 2026-09-27 — the null outcomes: time trial −0.03 [−0.14, 0.09], p=0.65 (k=42); VO2max −0.10 [−0.26, 0.05], p=0.20 (k=34); muscular strength 0.05 [−0.09, 0.19] (k=27); mean power output 0.14 [−0.03, 0.32] (k=18); graded exercise test 0.18 [−0.07, 0.42] (k=11); total work done 0.15 [−0.11, 0.40] (k=10).
Dose: subgroup analyses showed more pronounced time-to-exhaustion improvements with a minimum of 6 mmol/day (372 mg/day) and chronic (>3 days) supplementation.
Full text, checked 2026-09-27: benefits described as "more pronounced in non-athletes and recreationally active individuals, as compared with highly trained athletes", with a proposed ceiling effect in the already-optimised; muscular-endurance gains across all dose and duration subgroups.
Quality of the underlying reviews (AMSTAR-2): most ranged from low to critically low. full text, checked 2026-09-27: moderate 2 (10%), low 6 (30%), critically low 12 (60%); 60% did not use appropriate methods to combine results; none listed excluded studies with justification; one reported funding sources of included studies.
Practical Application
Across 20 meta-analyses (180 studies, 2672 participants), nitrate improved time to exhaustion (SMD 0.33), muscular endurance (0.48), distance covered (0.42) and peak power (0.25) — and no other performance outcome; time trial and VO2max were among the nulls (full text, checked 2026-09-27: time trial SMD −0.03 over 42 comparisons). Stop promising a faster time trial; for an event decided on sustained pace, nitrate is not the lever.
Where it does earn a place: efforts held to exhaustion, repeated near-maximal work, and peak power. Muscular endurance (0.48) and time to exhaustion (0.33) are the two defensible claims.
Dose it as a load, not a pill: at least 6 mmol/day for more than three days before the event, rather than a single serving on race morning — that is the subgroup where time-to-exhaustion gains were larger.
Scale the expectation to the athlete. Full text, checked 2026-09-27: the effect is reported larger in untrained and recreational athletes than in the highly trained.
Say the evidence quality out loud. Most pooled reviews were AMSTAR-2 low to critically low; this is a large literature of uneven quality, not a settled one.
Limitations
An umbrella review inherits its inputs. 20 reviews over 180 primary studies means substantial overlap between reviews, and most were AMSTAR-2 low to critically low.
full text, checked 2026-09-27: only 3 of the 20 reviews provided GRADE assessments (certainty very low to high); female representation in the reporting studies was 7-37%, and only three reviews analysed men and women separately.
Youth and older populations are largely absent (full text, checked 2026-09-27).
Full text, checked 2026-09-27: the authors note commercial beetroot products vary considerably in nitrate content — an athlete's real dose may not be the label dose.
Nitrate can interact with medications (nitrates prescribed for angina), and antibacterial mouthwash targets the oral bacteria of the conversion step. Neither is tested here; see REF-353, where both are carried as caution/practice.
How this entry was checked and changed
Content correction 2026-09-27
Null-outcome SMDs and k values, p values, AMSTAR-2 counts, the training-status quote, GRADE and female-representation figures and the product-variability note are not in the abstract; labelled full text (the abstract states only "no significant improvements for other outcomes, all p > 0.05" and "most low to critically low").
Added total distance covered to the title; lead now carries the abstract's pooled numbers.
Cross-references corrected: REF-358 is the IOC supplements consensus (not a microbiome paper); SYNTH-06 and SYNTH-08 carry nothing on nitrate and were removed; REF-353 no longer states a 2-3% time-trial gain.
Lines labelled "full text; not checked against the abstract" were checked against the open-access full text (PMC12106159): every number in them appears there; relabelled "full text, checked 2026-09-27".
Lines labelled "full text; not checked" were read against the open-access full text (PMC12106159): 5 confirmed and relabelled.